Latest Articles

Publication Date
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

First immunotherapy combination for endometrial cancer approved by NICE Oncology Central

Published: Aug. 6, 2025, 11:18 a.m.
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer NAVLIN DAILY

Published: Aug. 6, 2025, 9:30 a.m.
NICE recommends Keytruda for endometrial cancer - The Pharma Letter

NICE recommends Keytruda for endometrial cancer The Pharma Letter

Published: Aug. 6, 2025, 6:49 a.m.
NICE approves first immunotherapy combination for endometrial cancer - NICE website

NICE approves first immunotherapy combination for endometrial cancer NICE website

Published: Aug. 5, 2025, 11 p.m.
NICE approves new at-home treatment for endometriosis - Pharmacy Business

NICE approves new at-home treatment for endometriosis Pharmacy Business

Published: May 2, 2025, 5:23 p.m.
NHS patients to access Theramex’s endometriosis pill following NICE recommendation - PMLiVE

NHS patients to access Theramex’s endometriosis pill following NICE recommendation PMLiVE

Published: May 2, 2025, 11:13 a.m.
NICE Backs Oral Treatment Linzagolix for Endometriosis - Medscape

NICE Backs Oral Treatment Linzagolix for Endometriosis Medscape

Published: May 2, 2025, 7:15 a.m.
NICE approves once-a-day pill linzagolix for endometriosis - thepharmacist.co.uk

NICE approves once-a-day pill linzagolix for endometriosis thepharmacist.co.uk

Published: May 1, 2025, 1:20 p.m.
Up to 1,000 women a year could benefit from new at-home treatment for endometriosis - NICE website

Up to 1,000 women a year could benefit from new at-home treatment for endometriosis NICE website

Published: April 30, 2025, 11 p.m.
NICE Approves First-Ever Daily Pill for Endometriosis Treatment - geneonline

NICE Approves First-Ever Daily Pill for Endometriosis Treatment geneonline

Published: March 20, 2025, 9:03 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!